Kalliga Interactions
There are 456 drugs known to interact with Kalliga (desogestrel/ethinyl estradiol), along with 22 disease interactions, and 7 alcohol/food interactions. Of the total drug interactions, 50 are major, 359 are moderate, and 47 are minor.
- View all 456 medications that may interact with Kalliga
- View Kalliga alcohol/food interactions (7)
- View Kalliga disease interactions (22)
Most frequently checked interactions
View interaction reports for Kalliga (desogestrel / ethinyl estradiol) and the medicines listed below.
- amikacin
- amiodarone
- atropine
- azithromycin
- bupivacaine
- cefepime
- cefmetazole
- cefoperazone
- cefoxitin
- ceftizoxime
- ceftolozane / tazobactam
- ceftriaxone
- cefuroxime
- cephalothin
- chloramphenicol
- chymotrypsin ophthalmic
- ciprofloxacin
- cloxacillin
- colistimethate
- cyclophosphamide
- dexamethasone
- diphenhydramine
- dobutamine
- dopamine
- Dysport (abobotulinumtoxinA)
- epinephrine
- erythromycin
- etoposide
- filgrastim
- fosfomycin
Kalliga alcohol/food interactions
There are 7 alcohol/food interactions with Kalliga (desogestrel / ethinyl estradiol).
Kalliga disease interactions
There are 22 disease interactions with Kalliga (desogestrel / ethinyl estradiol) which include:
- smoking
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Kalliga (desogestrel / ethinyl estradiol)
- Kalliga consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.